Financials

  • Market Capitalization 45.73 M
  • Employee 115
  • Founded 1998
  • CEO N/A
  • Website www.celularity.com
  • Headquarter Delaware, United States
  • FIGI BBG00P2RTT34
  • Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-0.31
Relación precio/flujo de caja
1.07

Related tickers

#NombrePrecio24h %7d %1M %1A %CapitalizaciónÚltimos 7 días
4259
MCRB
Seres Therapeutics, Inc. - Common Stock
5.08 USD+2.63%+11.40%+7.17%-38.27%50.50 M USD
4281
TCRX
TScan Therapeutics, Inc. - Common Stock
0.75 USD0.00%-3.85%-2.60%-59.24%47.63 M USD
4292
HOWL
Werewolf Therapeutics, Inc. - Common Stock
0.94 USD-3.09%+10.59%+108.89%-32.86%45.68 M USD
4295
MGX
Metagenomi Therapeutics, Inc. - Common Stock
1.20 USD-0.83%-2.44%-0.83%-16.67%45.33 M USD

Noticias